Bancroft Robert E. has filed 3 insider transactions across 1 company since April 2025.
Most recent transaction: a grant/award of 3000000 shares of AEON Biopharma, Inc. ($AEON) on February 17, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | AEON Biopharma, Inc. | $AEON | Bancroft Robert E. | PRESIDENT & CEO | A | Class A Common Stock | 3000000 | $0.00 | 3,177,103.0000 | 11,634,946 | 1693.93% | 25.78% |
| May 14, 2025 | AEON Biopharma, Inc. | $AEON | Bancroft Robert E. | President & CEO | A | Class A Common Stock | 177103 | $0.00 | 177,103.0000 | 3,984,876 | 9999.99% | 4.44% |
| April 29, 2025 | AEON Biopharma, Inc. | $AEON | Bancroft Robert E. | President & CEO | A | Stock Option | 59034 | $0.00 | 59,034.0000 | 3,984,876 | 9999.99% | 1.48% |